Skip to content

Viatris VTRS Gross Profit

Gross Profit at other companies

Pfizer logo
PfizerPFE
$10.9B+0.3%
McKesson logo
McKessonMCK
$4.04B+11.1%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$143.88M+16.0%
Cencora logo
CencoraCOR
$3.59B+17.3%
AMP
Amphastar PharmaceuticalsAMPH
$70.32M-17.5%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$10.98M+117%

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$18.49B+81.7%
Enterprise value$31.3B+29.5%
P/S1.3×+0.5×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp
FCF margin12.3%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Calculated from Viatris’s reported figures.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's gross profit?
Viatris (VTRS) reported gross profit of $1.16B in Q1 2026.
How has Viatris's gross profit changed year-over-year?
Viatris's gross profit decreased by 0.3% year-over-year, from $1.16B to $1.16B.
What is the long-term trend for Viatris's gross profit?
Over 4 years (2021 to 2025), Viatris's gross profit has grown at a -2.6% compound annual growth rate (CAGR), from $5.58B to $5.01B.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.